Pravastatin Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 10 mg, 20 mg, 40 mg, 80 mg
Reference Brands: Pravachol(US & EU)
Category:
Heart Disorder
Pravastatin inhibits HMG-CoA reductase, reducing cholesterol synthesis in the liver. It lowers LDL cholesterol, boosts HDL, and decreases cardiovascular risk. Benefits include preventing heart attacks, strokes, and atherosclerosis, enhancing long-term heart health, improving lipid profiles, and supporting overall cardiovascular disease prevention.
Pravastatin is available in Tablet
and strengths such as 10 mg, 20 mg, 40 mg, 80 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Pravastatin is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Pravastatin can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Pravastatin tablets, marketed as Pravachol, are approved in the US by the FDA and in the EU via EMA for managing hyperlipidemia and preventing cardiovascular disease. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews comprehensive clinical trial and manufacturing data, while the EMA ensures compliance with regional safety and quality standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Ensuring accurate regional compliance supports timely approval, safe use, and worldwide availability of pravastatin tablets, helping millions worldwide lower LDL cholesterol and mitigate cardiovascular risk effectively.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing